Medicare AdvantageCoverageMedium impact
MA08.007ar, Medicare Part B vs. Part D Crossover Drugs
Independence Blue Cross·Pharmacy
Effective date
Jul 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage updated their policy MA08.007ar regarding crossover drugs between Medicare Part B and Part D coverage. This policy clarifies billing and coverage determination for drugs that may be covered under either Medicare benefit.
Action Required
By July 1, 2025: Billing team must review and update procedures for determining whether drugs should be billed under Medicare Part B or Part D. Verify coverage determination protocols for crossover drugs to ensure proper billing pathway and avoid claim denials.